Trademark: OPTIRINSE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for OPTIRINSE
We do not have any records of a proof of use for OPTIRINSE at this moment.
Possible trademark infringements of OPTIRINSE
Basic Information about OPTIRINSE
- Serial Number
- 97462011
- Filing Date
- 16 Jun 2022
- Registration Number
- 7319097
- Registration Date
- 05 Mar 2024
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of OPTIRINSE on the blockchain with WikiTrademarks.io.
- First use of OPTIRINSE anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
- First use of OPTIRINSE anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns OPTIRINSE?
1. Kobayashi Pharmaceutical Co., Ltd. Osaka,
2. Kobayashi Pharmaceutical Co., Ltd. Osaka,
3. Kobayashi Pharmaceutical Co., Ltd. Osaka,
Correspondent
- Karen Lim
- FROSS ZELNICK LEHRMAN & ZISSU, P.C.
- 151 WEST 42ND ST., 17TH FLOOR
- NEW YORK, NY 10036
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io